Concepedia

Sabrina Welland

SW

Statistics

Publications

4

Citations

156

H-Index

4

Active since

2022

Affiliations

Johannes Gutenberg University Mainz(Current)

University Medical Center of the Johannes Gutenberg University Mainz

Medizinische Hochschule Hannover

University Hospital Frankfurt

Medical University of Vienna

Sabrina Welland is an author at Johannes Gutenberg University Mainz specializing in oncology, liver cancer, and hepatocellular carcinoma treatment.

ORCID

Publications per year

2022–2024

4

Publications

4

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

Tiago B. R. Castro, Leonie Jochheim, Melanie Bathon et al. · Therapeutic Advances in Medical Oncology · 2022 · 79 citations · Full text

, , +17

Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study

Sabrina Welland, Catherine Leyh, Fabian Finkelmeier et al. · Liver Cancer · 2022 · 45 citations · Full text

, , +13

Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma—a European multicenter cohort

Katharina Pomej, Lorenz Balcar, Kateryna Shmanko et al. · ESMO Open · 2023 · 19 citations · Full text

, , +13

Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohort

Sabrina Welland, Leonie Jochheim, Kateryna Shmanko et al. · Hepatology Communications · 2024 · 13 citations · Full text

, , +13

1–4 of 4